Jorge Cuenca-Escalona

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Immune Response

Top Venues

European journal of immunology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Beatriz Subtil, Iris A E van der Hoorn, Jorge Cuenca-Escalona, Anouk M D Becker, Mar Alvarez-Begue, Kirti K Iyer, Jorien Janssen, Tom van Oorschot, Dennis Poel, Mark A J Gorris, Koen van den Dries, Alessandra Cambi, Daniele V F Tauriello, I Jolanda M de Vries
cDC2 plasticity and acquisition of a DC3-like phenotype mediated by IL-6 and PGE2 in a patient-derived colorectal cancer organoids model. European journal of immunology 54 (6) (2024)
Beatriz Subtil, Iris A E van der Hoorn, Jorge Cuenca-Escalona, Anouk M D Becker, Mar Alvarez-Begue, Kirti K Iyer, Jorien Janssen, Tom van Oorschot, Dennis Poel, Mark A J Gorris, Koen van den Dries, Alessandra Cambi, Daniele V F Tauriello, I Jolanda M de Vries
cDC2 plasticity and acquisition of a DC3-like phenotype mediated by IL-6 and PGE2 in a patient-derived colorectal cancer organoids model. European journal of immunology (2024)
Jorge Cuenca-Escalona, Georgina Flórez-Grau, Koen van den Dries, Alessandra Cambi, I Jolanda M de Vries
PGE2-EP4 signaling steers cDC2 maturation towards the induction of suppressive T cell responses. European journal of immunology (2023)
Camille Le Gall, Anna Cammarata, Lukas de Haas, Iván Ramos-Tomillero, Jorge Cuenca-Escalona, Kayleigh Schouren, Zacharias Wijfjes, Anouk M D Becker, Johanna Bödder, Yusuf Dölen, Ingrid Jolanda M De Vries, Carl G Figdor, Georgina Flórez-Grau, Martijn Verdoes
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion. Journal for immunotherapy of cancer 10 (4) (2022)